Article · Wikipedia archive · Last revised Jun 18, 2026

Butodesnitazene

Butodesnitazene is a benzimidazole derivative with opioid effects, which has been sold as a designer drug. It was identified by drug checking services in New Zealand in 2025, having been sold on the black market misrepresented as heroin. Its pharmacological properties have not been studied, although based on the known structure-activity relationships of the benzimidazole opioids, it is expected to have comparatively low potency.

Last revised
Jun 18, 2026
Read time
≈ 1 min
Length
133 w
Citations
1
Source
Wikipedia ↗
Butodesnitazene
Identifiers
  • 2-[(4-Butoxyphenyl)methyl]-1-(2-diethylaminoethyl)benzimidazole
Chemical and physical data
FormulaC24H33N3O
Molar mass379.548 g·mol−1
3D model (JSmol)
  • CCN(CC)CCn1c(nc2ccccc12)Cc1ccc(OCCCC)cc1
  • InChI=InChI=1S/C24H33N3O/c1-4-7-18-28-21-14-12-20(13-15-21)19-24-25-22-10-8-9-11-23(22)27(24)17-16-26(5-2)6-3/h8-15H,4-7,16-19H2,1-3H3
  • Key:NOCZAWHIDDFBFO-UHFFFAOYSA-N

Butodesnitazene is a benzimidazole derivative with opioid effects, which has been sold as a designer drug. It was identified by drug checking services in New Zealand in 2025, having been sold on the black market misrepresented as heroin. Its pharmacological properties have not been studied, although based on the known structure-activity relationships of the benzimidazole opioids, it is expected to have comparatively low potency.1

See also

See also

References

References